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Abstract 
The main objective was to develop and validate a method to assaying simultaneously nine residual solvents 
mentioned in the guidelines of the International Conference on Harmonization (ICH) Q3C: toluene, methanol, 
ethanol, acetone, propan-2-ol, ethyl acetate, tetrahydrofuran, dichloromethane and acetonitrile. Chromatographic 
separation was achieved on DB-624 column (30 m × 0.53 mm, 1.8 μm), nitrogen carrier gas and flame 
ionization detector. We have optimized the carrier gas flow, programming oven temperature and the split ratio. 
We have opted for the dimethyl sulfoxide as dissolution solvent. The developed method was validated for 
linearity, precision, accuracy and specificity and then applied for the research and quantification of residual 
solvents levels in two drug substances.  Excellent results were obtained. The developed method proved to be 
simple, producing symmetric peak shape, good resolution and reasonable retention time for solvents elution 
before seventeen minutes, specific, precise and linear in the range from the reporting level limit of quantification 
to 120% of the limit value, with a correlation coefficient greater than 0.999. The use of n-butyl acetate as 
internal solvent has improved the linearity and precision, compensating for the occurring variability. The 
quantification of residual solvents levels in two drug substances nefopam and enoxaparin, did not exceed the 
amount specified by the ICH guidelines.Thus, our method can be applied for the routine quantification of 
residual solvents levels in different active substances, for pharmaceutical companies and research laboratories. 
Keywords: Analytical validation; Flame Ionization Detection; Gas chromatography; Headspace; Residual 
solvents. 
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1. Introduction  
The residual solvents (RS) in pharmaceuticals are defined as organic volatile chemicals that are used or 
produced in the manufacture of active substances or excipients, or in the preparation of medicinal products. 
They are essential in each steps of pharmaceutical process (reaction, separation and formulation), improving the 
reactions performance, and the production of some characteristics for active substances such as crystalline form, 
solubility and purity. They are also used in lines production cleaning and to avoid any cross contamination 
following the good manufacturing practices [1].  
However the RS are not completely eliminated by the manufacturing techniques and their trace can remain in 
the finished product, which can influence on the organoleptic characters such as odor or taste to be unpleasant 
for patients, the effectiveness or therapeutically effect, bioavailability, security and stability of pharmaceutical 
products [2, 3]. Furthermore, they may also accelerate the decomposition process of the product. 
Many authors have published articles about polymorphism of pharmaceutical products and the influence of RS 
on their morphology, such as the influence of triethylamine as RS on the ampicillin trihydrate stability and 
degradation [3]. The RS main also interfere in the content-containing interactions, such as the transfer of 
plasticizing PVC (polyvinyl chloride) constituting the thermoformed alveoli, or additives from elastomer corks 
[3]. 
Since there is no therapeutic benefit from RS, which many of them are known to be hazardous to humans and 
the environment, all RS should be removed at the end of the manufacturing process to the extent possible, in 
order to meet product specifications and good manufacturing practices.  
The control of impurities in pharmaceutical products is the main goal of pharmaceutical industry analysts [4, 5]. 
The control must be in conformity with ICH Q3A (R2): impurities in new drug substances [6, 7] and ICH Q3B: 
impurities in new drug products [8]. 
The ICH has adopted Impurities Guidelines for RS and daily exposure limits (ICH guideline Q3C) [9]. Its 
objective is to recommend acceptable amounts of RS in pharmaceuticals for the safety of the patient, indicating 
the use of less toxic solvents and describing levels considered to be toxicologically acceptable. Four different 
classes are described: solvents that are known to cause unacceptable toxicities (Class 1) should be avoided in the 
production of active substances, excipients, or medicinal products unless their use can be strongly justified in a 
risk-benefit assessment ; solvents associated with less severe toxicity (Class 2) should be limited in order to 
protect patients from potential adverse effects. Ideally, less toxic solvents (Class 3) should be used where 
practical. The class 4 includes solvents for which no adequate toxicological data was found.  
Conforming to ICH guidelines, class 1 solvents need to be identified and quantified, solvents from class 2 
should have individual limits between 50 and 5000 ppm, and solvents from class 3 must be identified and 
quantified when they are found to be more than 0.5% (w/w). 
The first analytical method for RS, which was published in pharmacopoeias, was a loss of weight, which is a 
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simple and not demanding method, but it has many disadvantages, including lack of specificity, high limit of 
detection (about 0.1%), and a relatively large amount of sample needed to perform the tests (about 1 to 2 g).  
Gas chromatography (GC), because of its excellent separation abilities, low limit of detection, and due to the 
volatility of organic solvents and the substantial separating capability of capillary columns, has dominated 
analytical methods for RS determinations. In GC, the sample is either dissolved in a suitable solvent than 
injected directly [10, 11] or by headspace sampling [12, 13]. Headspace sampling is preferred because of its 
ability to avoid direct liquid or solid probing. In the headspace sampling complex sample matrix in a solid or 
liquid sample matrix in liquid or solid sample can be simplified or even eliminated in its vapor phase [14]. 
The European monograph under chapter 2.4.24 «Identification and control of residual solvents» [15] presents 
two procedures A and B which are useful to identify and quantify RS. The system A is recommended for 
general use, while system B is employed normally for confirmation of identity. Both system use static 
headspace GC with flame ionization detection (FID). 
This general method may be used for identification of class 1 and 2 RS when there is no information about 
solvents which likely to be present in the specimen ; as a limit test for class 1 and 2 solvents when they are 
detected in the sample ; for quantification of class 3 solvents when it is required.  
Implementation of this general method is a subject of debate in the pharmaceutical industry because of its 
limited selectivity and sensitivity [16]. Otherwise, some studies of technical problems have been noted, for 
example, artifact formation during analyses of hydrochlorides of basic compounds in N,N-dimethylformamide 
[17]. Moreover, this general method does not recommend the use of internal standard although it may overcome 
the matrix interferences and enhance the accuracy and precision of GC analysis. The internal standard 
efficiently compensates for the variables occurring during sample extraction and injection, especially for 
complex sample preparation procedure [16, 18, 19]. Furthermore, the European Pharmacopeia’s general method 
has a long run time to achieve the satisfactory separation for all solvents. For this reason, manufacturers try to 
find their own methods which would be quicker, easier and adaptable to their specific samples and analytes [16, 
20]. Several authors have developed methodologies for determination of RS in pharmaceuticals [21, 22]. 
The aim of this work is to develop an analytical method for the simultaneous separation of nine RS, commonly 
used in active substances manufacturing belonging to class 2 and 3, by GC with headspace injector, starting 
from the European Pharmacopoeia recommended conditions and by optimizing several parameters in order to 
improve the analytical performance such as resolution, run time, precision and accuracy; then to validate the 
new developed method, improving the linearity and fidelity criteria by the use of an internal standard; and 
applying it to the research and quantification of RS likely to be present in drug substances, such as methanol, 
toluene levels in nefopam; and methanol, ethanol levels in enoxaparin. 
2. Experimental 
2.1. Active substances and reagents  
Enoxaparin and nefopam raw materials were procured respectively from TECHDOW (china) and ISOCHEM 
American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2018) Volume 41, No  1, pp 57-75 
 
60 
(France).All solvents and reagents used in this study were analytical grade (HPLC grade). The solvents from 
class 2 and 3 namely methanol, acetonitrile, dichloromethane, toluene, ethanol, acetone, ethyl acetate, propan-2-
ol, tetrahydrofuran (THF), ethyl acetate, n-butyl acetate and dimethylsulfoxide (DMSO) were purchased from 
SIGMA ALDRICH (TUNISIA).  
2.2. Apparatus: Headspace gas chromatography 
A GC (AGILENT Technologies G1530A) is equipped with Agilent 7694 Headspace injector, coupled to FID. A 
capillary column DB 624 with 30 m long, 0.53 mm in inner diameter and 1.8 µm in film thickness (Agilent) was 
used.  
Table1: European Pharmacopeia conditions (System A) 
Sample 
preparation 
Water-
soluble 
articles 
About 250 mg of the tested material dissolved in a 25 mL volumetric flask with 
water and then 5.0 mL of this solution transferred to head space vial filled with 
1.0 mL of water. 
Water-
insoluble 
articles 
About 500 mg of the tested material dissolved in a 10 mL volumetric flask with 
N,Ndimethylformamide and then 1.0 mL of this solution transferred to head space 
vial filled with 5.0 mL of water. 
Injection source Head space sampler. 
Stationary 
phase Nature Cross linked mixture: (6%) Cyanopropyl-phenyl- (94%) dimethylpolysiloxane. 
Column 
support Fused silica capillary or semi capillary. 
type 
30 m×0.32 mm column coated with 1.8 μm layer of stationary phase (only for 
water soluble articles) or a 30 m× 0.53 mm wide-bore column coated with a 3.0 
μm layer of stationary phase. 
Carrier gas Nitrogen or helium. 
Carrier gas velocity About 35 cm/s. 
Injection port temperature 140°C. 
Split ratio 1:5 for water soluble articles and 1:3 for water insoluble articles (can be modified to optimize sensitivity). 
Temperature program 40°C for 20 min, then raised to 240°C with rate 10°C per min and then maintained at 240°C for 20 min. 
Detector type FID or MS (Mass spectrometry). 
Detector temperature 250°C. 
 
The acquisition and treatment of data were achieved by using a computer equipped with Agilent ChemStation 
Software 3.2.1 version.  
The other used materials were a balance (Denver Instrument SI-234), glassware as volumetric double line 
pipettes, flask, a beaker, and calibrated micropipettes.   
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2.3. General procedure 
2.3.1. European Pharmacopeia conditions 
In this study, System A conditions from the European Pharmacopeia was selected for method development and 
validation (table 1) [15]. 
2.3.2. Optimization of GC conditions 
The developed method by GC coupled to headspace injector should allow the simultaneous research and 
quantification of nine RS: toluene, methanol, ethanol, acetone, propa-2-ol, acetonitrile, dichloromethane, ethyl 
acetate, THF. We had started following the conditions of the European Pharmacopeia’ System A. As the 
obtained results were insufficient, such as a long run time and a poor resolution, we had proceeded to optimize 
the carrier gas flow, programming oven temperature and the split ratio. 
2.3.3. Standard and sample preparation  
Sample preparation solution S1 at concentration 0.1 g/ml was prepared by dissolving accurately weighted about 
0.5 g of the active substance to be analysed into an Agilent technologies manufactured 20 ml flat bottom 
headspace GC vials, adding 5.0 ml of the solution S2, then sealing vial properly fitted with a septum and crimp 
cap. 
The internal standard solution S2 at concentration 0.2 mg/ml was prepared by introducing 30 ml of DMSO in a 
250 ml volumetric flask and adding accurately weighted about 50 mg of n-butyl acetate, completing up to the 
mark with DMSO. 
The standard solution S3 was prepared by introducing 30 ml of the solution S2 in a 100 ml volumetric flask, and 
adding accurately weighted about 500 mg acetone, 500 mg ethanol, 500 mg propan-2-ol, 500 mg ethyl acetate, 
300 mg methanol, 60 mg dichloromethane, 89 mg toluene, 41 mg acetonitrile and 72 mg THF. This standard 
solution S3 contains about 0.5 mg/ml of acetone, 0.5 mg/ml of ethanol, 0.5 mg/ml of propa-2-ol, 0.5 mg/ml of 
ethyl acetate, 0.3 mg/ml of methanol, 0.06 mg/ml of dichloromethane, 0.089 mg/ml of toluene, 0.041 mg/ml of 
acetonitrile and 0.072 mg/ml of THF. These quantities compared to the active substance, correspond to the 
European Pharmacopeia’ fixed limits to 5000 ppm of acetone, 5000 ppm of ethanol, 5000 ppm of propan-2-ol, 
5000 ppm of ethyl acetate, 3000 ppm of methanol, 600 ppm of dichloromethane, 890 ppm of toluene, 410 ppm 
of acetonitrile, and 720 ppm of THF [15]. 
2.4. Validation of the developed method  
Validation was carried with respect to various parameters as required under ICH guideline Q2 (R1) [23-26].  
2.4.1. Specificity and selectivity 
The selectivity was determined by analysis of the blank solution containing the dissolution solvent and the 
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internal standard, to the standard solution containing the nine RS mixture diluted in DMSO (solution S3).  
The specificity of the method was evaluated by the resolution factor Rs between each nearest peak.  
2.4.2. Linearity 
Linearity was determined in duplicate by cascade dilution series from a standard solution (S4) at 120% of nine 
RS mixture. ICH Q2B specifies minimum linearity range from the reporting level of quantification limit to 
120% of the limit value [24]. Six concentrations were selected in this study. We had checked the linearity for all 
the RS mentioned in this study, by the correlation coefficient R2. 
The standard solution at 120% (S4) was prepared by introducing 30 ml of S2 solution into 100 ml volumetric 
flask and adding accurately 600 mg of acetone, 600 mg of ethanol, 600 mg of propan-2-ol, 600 mg of ethyl 
acetate, 360 mg of ethanol, 72 mg of dichloromethane, 106.8 mg of toluene, 49.2 mg of acetonitrile and 86.4 mg 
of THF. A 1/10 dilution with solution S2 was done, then we pipetted 2 ml of this solution into 20 ml headspace 
GC vial and we properly sealed vial fitted with a septum and crimp cap. 
2.4.3. Accuracy 
Accuracy was determined in triplicate at three concentration levels (120%, 100% and 80%) from S4 solution, 
and by adding 0.5 g of the active substance. The percent recovery was calculated as the ratio between the found 
and the introduced quantity of the RS, that’s mean the observed and true value. The accuracy was checked for 
two active substances nefopam and enoxaparin, which the RS likely to be present are methanol and toluene for 
nefopam, and methanol and ethanol for enoxaparin.  
2.4.4. Precision 
The precision of an analytical procedure expresses the closeness of agreement (degree of scatter) between a 
series of measurements obtained from multiple sampling of the same homogeneous sample under the prescribed 
conditions. Precision may be considered at three levels: repeatability, intermediate precision and reproducibility. 
The precision of an analytical procedure is usually expressed as the variance, standard deviation (SD) or 
coefficient of variation of a series of measurements. Method precision shall be established by determining the 
assay in six different preparations of a reference solution. Intermediate precision shall be determined by 
studying the variation in assay of a homogeneous sample analyzed by two different equipment, or analyst or 
days. 
In our study, the intra-day and inter-day precision, which are the most required criteria,  had been established by 
analysing the drug solution in 6 replicate injections on the same day and on three consecutive days, respectively. 
The value of SD and relative standard deviation (RSD) were calculated. 
2.4.5. Limit of detection and limit of quantification 
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The limit of detection (LOD) of an individual analytical procedure is the lowest amount of analyte in a sample, 
which can be detected but not necessarily quantified as an exact amount. While the limit of quantification 
(LOQ) is the minimum level of concentration at which the analyte can be quantified with acceptable precision 
and accuracy [23]. 
The LOD and LOQ are expressed from the standard deviation σ of the responses (the intercept) and the slope s 
of the calibration line [27]. Kumar and his colleagues have also used the same statistics [27]. Some authors have 
opted to the base line noise for the estimation of these limits [22, 28, 29]. 
3. Results and Discussion 
3.1. Optimization of separation conditions 
3.1.1. Preliminary experiences 
The results obtained following the European Pharmacopeia’ System A conditions are insufficient, such as a long 
run time (30 min) and a poor resolution (Rs<1) with loss of elution time for about 13 min between the THF and 
toluene peaks (Fig. 1), so the method was optimized for the detect and quantification the nine RS with a 
satisfactory resolution Rs in a short run time using an internal standard.  
 
Figure 1: Chromatogram of residual solvents under the European Pharmacopeia conditions. 
3.1.2. Selection of the column type 
In the literature, many stationary phases have been used such as column BP1 (100% dimethylsiloxane) [30], 
DB-FFAP (polyethylene glycol modified to nitroterephtalic acid) [27], DB-WAXETR (polyethylene glycol) 
[22]. In our study, after many trials, we have opted for the column DB-624 presenting the same characteristics 
of that of the European Pharmacopeia, and which is designed specifically for the analysis of RS. This column 
has contributed to the best separation, with good resolution (Rs > 2). 
3.1.3. Selection of dissolution solvent 
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The choice of dissolution solvent should be judicious, because it affects the sensibility, equilibration 
temperature and time. The dissolution solvent should allow dissolution of many samples; have a high boiling 
point, and acceptable stability [21]. The most used ones for the GC analysis with headspace injector are water, 
DMSO, N,N-dimethylformamide, N,N-dimethylacetamide, benzyl alcohol, 1,3-dimethyl-2-imidazolidinone, and 
mixture of water/N,N-dimethylformamide and water/DMSO [31]. The water is a good solvent for soluble 
substances, the use of water/N,N-dimethylformamide and water/ DMSO mixture increase the solubility of many 
drugs, also the partition coefficient of the substances decrease which improve their transfer from liquid to gas 
phase. However, if the equilibration temperature of the drug is near to the boiling point of the solvent, the 
pressure in the vial can increase dangerously [21] and if we choose the mixture of water/N,N-
dimethylformamide and water/ DMSO, the equilibration temperature by headspace injector should be lower 
than 100°C, which lead to poor volatilization of solvent having high boiling point. In our study, we have chosen 
the DMSO due to its polarity and capacity to solubilise many organic compounds, with low toxicity, and the 
possibility to incubate the vial at high temperature superior to 100°C [32]. Many authors have also used DMSO 
as dissolution solvent [27- 29, 32]. Siddiqui and his colleagues have used N,N-dimethylformamide for the 
development of a method for the control of nine RS in docetaxel [22]. 
3.1.4. Selection of the internal standard 
The internal standard should have a chromatographic behavior very similar to that of the compound to be 
assayed, doesn’t interfere with other possibly presented substances, having identical properties regarding the 
detection system, and available in high purity. We have opted to n-butyl acetate as internal solvent which is 
from class 3, not much used in the synthesizing process of the active substances. Its use has lead to the 
correction of the variability caused by the GC method with headspace system. In literature, Teglia and his 
colleagues have used four internal standards: benzene and trichloroethylene for the quantification of solvents 
with low limits, hexane and acetone for the quantification of solvents with high limit [32]. Clécio S R, has used 
the dioxane as internal standard for the analysis of seven RS [28]. However, there are many developed method 
in literature that have not used an internal standard [22].  
3.1.5. Optimization of the carrier gas flow 
The decrease of the carrier gas flow from 2.1 ml/min (35 cm/s) to 1 ml/min (19 cm/s) has improved the 
separation between the nearest peaks. 
3.1.6. Optimization of the split ratio 
The split ratio was varied in the range between 1/5 and 1/1. By a split ratio 1/1, we have obtained a satisfactory 
sensibility.  
3.1.7. Optimization of the oven temperature program 
In order to obtain a short analysis time, we have proceeded to the modification of the oven temperature program. 
By refereeing to previous studies in literature, (table 2), and after several assays of temperature changing 
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program, we have selected this program: 40°C for 8 min, then raising to 90°C at a rate of 10°C/min, then raising 
to 240°C at a rate of 40°C/min, keeping this final temperature for 5 min.   
Table 2: Summary of some studies in literature for gas chromatography (GC) conditions 
 
3.2. Selected conditions 
From the studies carried out before, we propose the GC method procedure summarized in table 3. 
The typical chromatogram obtained in the separation of nine RS under the optimized conditions, is presented in 
Fig. 2. Good resolution (Rs > 2), symmetric peak shapes for every component and reasonable retention time for 
all the solvents can be seen.  
 
 
Study Headspace Column Carrier 
gas 
Oven Injection 
port 
Detector 
Kumar.,  and 
his colleagues 
[27] 
Manual injection DB-FFAP, 
30m×0.53 mm, 
coated with 1.8 
μm layer of 
stationary phase.  
Nitrogen 
45°C 5 min, 
5°C/min, 
85°C, 
12°C/min, 
220°C 
220°C FID 
260°C 
Clécio S, 
R.[28] 
European 
Pharmacopeia 
conditions 
ZB-624, 
30m×0.32 mm 
35°C &à min, 
15°C/min, 
40°C 10 min, 
18°C/min, 
235°C 8 min, 
return to 35°C 
- FID 
Siddiqui.,  and 
his colleagues 
[22] 
Equilibrium 
temperature 100°C, 
equilibrium time 20 
min, transferring 
temperature 120°C, 
pressurizing time 2 
min,  
Polyethylene 
glycol, DB-
WAXETR, 
60m×0.250 
mm; coated with 
0.25 μm layer of 
stationary phase. 
40°C 5 min, 
10°C/min, 
240°C 5 min, 
return to 40°C 
250°C FID, 
270°C 
Sivasaikiran, 
B. [29] 
Equilibrium 
temperature 40°C,  
DB-624, 
30m×0.53 mm, 
coated with 3.0 
μm layer of 
stationary phase.  
Helium 40°C 6 min, 
10°C/min, 
130°C 8 min, 
35°C/min, 
240°C 5 min 
100° FID 
250°C 
Teglia, C.M.,  
and his 
colleagues 
[32] 
Equilibrium 
temperature 105°C, 
equilibrium 
temperature 45 min, 
injection 2.5 ml of 
gas phase 
DB 624, 
30m×0.53 mm, 
coated with 3.00 
μm layer of 
stationary phase. 
Nitrogen 40°C 20 min, 
10°C/min, 
240°C 20 min 
- FID 
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Table 3: GC retained conditions 
Stationary 
phase 
Nature (6%) polycyanopropyl-phenyl-siloxane (94%) poly-dimethyl-siloxane. 
Type 30 m × 0.53 mm wide-bore column coated with 1.8 μm layer of stationary phase. 
Carrier gas Nature Nitrogen 
Flow 1 ml/min 
Split ratio 1:1 
Oven Temperature Kept at 40°C for 8 min, then raised to 90°C at a rate of 10°C/min, then raised to 
240°C at a rate of 40°C/min. This final temperature was held up to 5 min.   
Injection 
port  
temperature 140°C 
Detector  type FID 
temperature 250°C 
 
Figure 2: Chromatogram of the nine residual solvents in the reference solution under the optimized conditions. 
3.3. Validation results 
3.3.1. Specificity and selectivity 
The peaks of n-butyl acetate and DMSO don’t interfere with the other peaks (Fig. 3), and the Rs is superior to 2 
between each nearest peak (table 4). 
3.3.2. Linearity  
Without the use of the internal standard, the criteria R2>0.999 is not valid for all the analysed RS, although in 
literature for many studies, R2>0.99 is considered as acceptable [29, 32]. After adding of n-butyl acetate, a good 
linear relationship was obtained for each RS between concentrations and peak area showing well that the 
method . 
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Figure 3: Chromatogram of the blank solution containing the dissolution solvent and the internal standard. 
Table 4: RT (retention time), RRT (relative retention time) and Rs of the residual solvents (RS) analysed 
simultaneously 
Analysed solvent RT (min) RRT   Rs (resolution) 
Methanol 4.28 0.27  
Ethanol 5.70 0.37 10.89 
Acetone 6.67 0.43 7.03 
Propan-2-ol 7.05 0.45 2.69 
Acetonitrile 7.41 0.47 2.44 
Dichloromethane 7.91 0.51 3.52 
Ethyl acetate 11.27 0.72 27.5 
THF 11.67 0.75 4.02 
Toluene 15.04 0.96 47.64 
n-butyl acetate 15.61 1.00 14.17 
DMSO 16.00 1.02 12.85 
Table 5: Calibration curves of RS 
Without the use of the internal standard With the use of the internal standard 
Analysed solvent Linear regression curve R2 Linear regression curve R2 
Methanol Y= 0.0371x-7.3232 0.9665 Y= 0.001x-0.107 0.999 
Ethanol Y= 0.0529x-08091 0.9977 Y= 0.001x-0051 0.999 
Acetone Y=0.2196X-27.326 0.9953 Y=0.004x-0.026 0.999 
Propan-2-ol Y= 0.0661X-9.6613 0.9932 Y= 0.0014x-0.0266 0.9994 
Acetonitrile Y=0.0861x-0.2571 0.9904 Y=0.0018-0026 0.999 
Dichloromethane Y=0.0529x-0.0306 0.9885 Y=0.0011x-0.0038 0.9992 
Ethyl acetate Y=0.161X-17.228 0.9946 Y=0.0033x+0.0766 0.9998 
THF Y=0.257x+34.886 0.9598 Y=0.0057x+0.7265 0.9998 
Toluene Y=0.3271X+8.6573 0.9558 Y=0.0051x+0.3387 0.9995 
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reporting level limit of quantification to 120% of the limit value, with a correlation coefficient greater than 
0.999.  In all cases, the intercepts were considered as negligible by using the student’s t-test (α=0.05).The 
statistical results before and after the use of an internal standard are shown in table 5, showing well the role of 
an internal standard in improving the method’s linearity. 
3.3.3. Limit of detection and quantification  
The LOD and LOQ were estimated by using the following formulae: (1) and (2). 
Limit of detection= 3.3 × 𝜎𝜎 
𝑠𝑠
                                                                                         (1) 
Limit of quantification= 10 × 𝜎𝜎 
𝑠𝑠
                                                                                  (2) 
The results are shown in table 6. The obtained values of our method are high compared to certain values found 
in the literature because the equipment is relatively old. But these rates are well below those required by ICH 
specifications for the analysed RS [9], so we can conclude that our method enables the quantification of these 
solvents. 
Table 6: Limits of detection and quantification in ppm 
Solvent LOD (ppm) LOQ (ppm) 
Methanol 76.65 232.28 
Ethanol 83.97 118.09 
Acetone 59.97 181.73 
Propan-2-ol 83.59 253.29 
Acetonitrile 9.41 28.52 
Dichloromethane 9.58 29.02 
Ethyl acetate 65.08 197.22 
THF 14.36 43.52 
Toluene 19.38 58.71 
 
3.3.4. Precision  
The data obtained from precision experiments for intra-day precision studies shows that the % SD values are 
less than 5.0%, mainly after adding the internal standard (table 7), confirming that the method is sufficiently 
precise. 
For the inter-day precision, without adding the internal standard, the method is not precise (RSD > 6% for some 
RS) (table 8), showing a high variability, but after adding the internal standard, % RSD values are less than 6%, 
showing well the role of internal standard in the improving of the method’s precision.  
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In literature, the standard deviation of repeatability varies from one study to another. 
Table 7: Intra-day precision studies 
Analysed 
solvent 
SD (%) before the use of the internal 
standard 
SD (%) after the use of the internal 
standard 
Methanol 2.81 3.12 
Ethanol 1.93 1.56 
Acetone 1.31 1.15 
Propan-2-ol 1.5 0.47 
Acetonitrile 3.53 4.80 
Dichloromethane 1.00 2.12 
Ethyl acetate 3.66 3.52 
THF 1.26 0.79 
Toluene 1.47 0.29 
 
Table 8: Inter-day precision studies 
Concentrations Recovery study for methanol Recovery study for toluene 
Recovery % Mean (%) ± S.D Recovery % Mean (%)± S.D 
120% 
81.12 
88.37 ± 7.85 
93.67 
97.01±2.93 87.28 98.25 
96.70 99.12 
100% 
99.01 
102.12 ± 3.98 
100.02 
101.36±1.54 106.60 103.04 
100.75 101.02 
80% 
97.09 
93.82 ± 2.84 
98.87 
101.62±2.62 92.04 104.10 
92.32 101.88 
 
3.3.5. Accuracy  
Recovery of individual solvents was calculated using the following formula (3). 
Recovery % (spiked 80% or 100% or 120%) for a particular solvent= 
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑝𝑝𝐴𝐴𝐴𝐴𝑝𝑝 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑜𝑜𝑜𝑜 𝑠𝑠𝑝𝑝𝑠𝑠𝑝𝑝𝐴𝐴𝑠𝑠 𝑠𝑠𝑜𝑜𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑜𝑜𝑠𝑠 −𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑝𝑝𝐴𝐴𝐴𝐴𝑝𝑝 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑠𝑠 𝑠𝑠𝑝𝑝𝑠𝑠𝑝𝑝𝐴𝐴𝑠𝑠 𝑠𝑠𝑜𝑜𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑜𝑜𝑠𝑠
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑝𝑝𝐴𝐴𝐴𝐴𝑝𝑝 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑠𝑠𝑠𝑠 𝑠𝑠ℎ𝐴𝐴 𝐴𝐴𝐴𝐴𝑜𝑜𝐴𝐴𝐴𝐴𝐴𝐴𝑠𝑠𝑟𝑟𝐴𝐴 𝑠𝑠𝑜𝑜𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑜𝑜𝑠𝑠  × 100                               (3) 
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The accuracy of the method was checked for two active substances nefopam and enoxaparin, which the RS 
likely to be present are methanol, toluene for nefopam, and methanol, ethanol for enoxaparin.  
The mean recoveries (mean± S.D.) were calculated for each solvent. As shown from data in tables 9 and 10, we 
have obtained excellent recoveries between 85% and 115%.  
Table 9: Recovery study of RS in nefopam 
 Before the use of an internal standard After the use of an internal standard 
SD (%) RSD 
(%) 
SD (%) RSD (%) 
Analysed solvent J1 J2 J3 J1 J2 J3 
Methanol 2.13 2.81 1.97 11.02 2.56 3.12 1.11 5.28 
Ethanol 1.59 1.93 2.02 5.17 2.16 1.56 2.02 5.17 
Acetone 0.94 1.31 0.79 5.95 1.69 1.15 1.05 4.04 
Propan-2-ol 1.73 1.5 1.09 4.62 1.67 0.47 0.68 5.43 
Acetonitrile 3.08 3.53 1.46 6.18 4.29 4.80 1.35 4.92 
Dichloromethane 1.12 1.00 1.95 12.06 1.77 2.12 1.11 4.55 
Ethyl acetate 1.33 3.66 0.76 6.83 1.30 3.52 1.10 3.34 
THF 1.89 1.26 1.24 17.00 1.89 1.26 1.24 5.44 
Toluene 1.61 1.47 0.79 15.10 1.13 0.29 1.57 5.50 
 
Table 10: Recovery study of RS in enoxaparin 
Concentrations Recovery study for methanol Recovery study for ethanol 
Recovery % Mean (%) ± S.D Recovery % Mean (%)± S.D 
120% 
97.04 
99.47 ±2.11 
92.59 
91.05±1.40 100.51 89.84 
100.85 90.73 
100% 
106.11 
108.30±2.29 
95.06 
96.79±1.51 111.00 97.49 
107.79 97.83 
80% 
111.48 
110.76±2.80 
101.28 
100.31±3.00 107.36 96.95 
113.45 102.71 
 
For some authors, range from 90% to 110% or 80% to 120% have been accepted [27, 29]. Many authors have 
opted to the Student test statistics, which tcalculated should be inferior to ttable [28, 29].  
We can conclude that our method enables quantification of RS limits with satisfactory accuracy. 
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3.4. Application 
The developed method was applied to the research and quantification of RS likely to be present in some drug 
substances.  
The analyzed sample of nefopam doesn’t contain any trace of methanol and toluene. The obtained 
chromatogram only shows the internal standard and DMSO peaks. 
The chromatogram obtained for enoxaparin sample shows the peaks of methanol and ethanol; which their LOQ 
are calculated following the formula (4).  
Solvent content in ppm = 𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆×𝐴𝐴𝐸𝐸×106
𝐴𝐴𝑆𝑆𝑆𝑆𝑆𝑆 ×𝐶𝐶𝐸𝐸                                                                     (4) 
CSTD is the concentration of solvent in the standard solution (mg/ml); CE is the concentration of the active 
substance in the examined solution (mg/ml); AE is the ratio of the peaks area in the examined solution; ASTD is 
the ratio of peaks area in the standard solution. 
The obtained results for methanol and ethanol levels are respectively 42.35 ppm and 41.92 ppm; which are 
widely inferior to the amount specified by the ICH guidelines, 3000 ppm and 5000 ppm respectively. 
4. Conclusion 
The presence of RS is essential in each step of pharmaceutical process, and since there is no therapeutic benefit, 
the control and quantification of their limits in active substances and finished products are essential, due to their 
toxicity, hazardous effects to humans and environment and on the effectiveness, bioavailability, security and 
stability of pharmaceutical products. 
The ICH has adopted Impurities Guidelines for RS. Its objective is to recommend acceptable amounts of RS in 
pharmaceuticals for the safety of the patient, indicating the use of less toxic solvents and describing levels 
considered to be toxicologically acceptable. 
The European Pharmacopeia has adopted a reference method for the control of RS, enabling only the 
quantification of class 3 solvents, so it is important to develop other internal methods and validate them before 
using in routine control.  
In our study, we have developed and optimized an analytical method which enables the research and 
quantification of nine RS levels from class 2 and 3. The preliminary experiences were opted from the European 
Pharmacopeia, and as the obtained results are insufficient, such as a long run time and a poor resolution, we 
have proceeded to optimization. 
The developed GC method with FID offers simplicity and selectivity, producing symmetric peak shape, good 
and reasonable retention time for various solvents, as it can be seen from the chromatogram that all the solvents 
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were eluted before seventeen minutes of injection of sample. The method is specific (Rs>2); precise (SD < 5% 
for repeatability, and RSD <6% for intermediate precision); and linear in the range from the reporting level limit 
of quantification to 120% of the limit value, with a correlation coefficient greater than 0.999. The use of n-butyl 
acetate as internal solvent, has improved the linearity and precision of the method compensating for the 
occurring variability. 
The developed method was applied to the research and quantification of RS levels in two drug substances 
nefopam and enoxaparin. The obtained results did not exceed the amount specified by the ICH guidelines. Thus, 
our method may be applied for the routine quantification of RS levels in different active substances, for 
pharmaceutical companies and research laboratories. 
5. Recommendations 
The acquisition of new equipment could improve the sensitivity of the method and the coupling of the GC to 
mass spectrometry (GC-MS) or to tandem mass spectrometry (GC-MS/MS) is of great interest for the 
identification and quantification of residual solvents. 
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